AG Brown joined a coalition of 48 states and territories announcing a $29.6 million settlement with Glenmark to resolve allegations that the generic drug manufacturer engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. Maryland’s share of today’s settlement is $178,000.

“For years, Glenmark colluded to drive up prices for drugs that are meant to be an affordable option, forcing Marylanders to pay inflated prices for medications they depend on. This settlement provides monetary relief for those Marylanders and requires Glenmark to reform its conduct so competition, not collusion, sets the price Marylanders pay.” -AG Brown